Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals

Clinical Microbiology and Infection

Volumn 17, Issue 10, 2011, Pages 1524-1528

  Bonnin, R A ^a   Poirel, L ^a   Licker, M ^b   Nordmann, P ^a  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^b Department of Microbiology   (Romania)

Author keywords

Acinetobacter baumannii; Carbapenemase; Extended spectrum lactamase; OXA 23; OXA 58

Indexed keywords

BETA LACTAMASE; CARBAPENEM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLA OXA 23; BLA OXA 58 GENE; CHROMOSOME; CLINICAL FEATURE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYDROLYSIS; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; ROMANIA; SEQUENCE ANALYSIS; TRANSPOSON;

ACINETOBACTER BAUMANNII;

EID: 80053052744     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03622.x     Document Type: Article

References (29)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-582.
2. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-836.
3. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D ß-lactamases. Antimicrob Agents Chemother 2010; 54: 24-38.
4. Héritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 4174-4179.
5. Bou G, Cerveró G, Domínguez MA, Quereda C, Martínez-Beltrán J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of ß-lactamases. J Clin Microbiol 2000; 38: 3299-3305.
6. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 2006; 50: 2941-2945.
7. Marqué S, Poirel L, Héritier C et al. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 2005; 43: 4885-4888.
8. Poirel L, Lebessi E, Héritier C, Patsoura A, Foustoukou M, Nordmann P. Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece. Clin Microbiol Infect 2006; 12: 1138-1141.
9. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010; 16: 35-40.
10. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006; 43: S49-S56.
11. Bonnin RA, Nordmann P, Potron A et al. Carbapenem-hydrolyzing GES-type extended-spectrum ß-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 349-354.
12. Bonnin RA, Potron A, Poirel L, Lecuyer H, Zahar JR, Poirel L. PER-7, an extended spectrum β-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 2424-2427.
13. Fournier PE, Vallenet D, Barbe V et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2: e7.
14. Moubareck C, Brémont S, Conroy MC, Courvalin P, Lambert T. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother 2009; 53: 3579-3581.
15. Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum β-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother 2006; 58: 178-182.
16. PER-1 gene in gram-negative bacteria. Antimicrob Agents Chemother 2005; 49: 1708-1713.
17. Poirel L, Karim A, Mercat A et al. Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J Antimicrob Chemother 1999; 43: 157-158.
18. Ibrahim A, Gerner-Smidt P, Liesack W. Phylogenetic relationship of the twenty-one DNA groups of the genus Acinetobacter as revealed by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997; 47: 837-841.
19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.
20. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J Clin Microbiol 2011; 49: 718-721.
21. Adams-Haduch JM, Paterson DL, Sidjabat HE et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother 2008; 52: 3837-3843.
22. OXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50: 1442-1448.
23. Mugnier P, Poirel L, Pitout M, Nordmann P. Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin Microbiol Infect 2008; 14: 879-882.
24. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13: 807-815.
25. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 2010; 5: e10034.
26. Nemec A, Krízová L, Maixnerová M et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother 2008; 62: 484-489.
27. Stoeva T, Higgins PG, Savov E, Markovska R, Mitov I, Seifert H. Nosocomial spread of OXA-23 and OXA-58 β-lactamase-producing Acinetobacter baumannii in a Bulgarian hospital. J Antimicrob Chemother 2009; 63: 618-620.
28. Goic-Barisic I, Towner KJ, Kovacic A et al. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. J Hosp Infect 2011; 77: 368-369.
29. Göttig S, Pfeifer Y, Wichelhaus TA et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010; 10: 828-829.